Section Arrow
Quote
ANIP.NASDAQ
- ANI Pharmaceuticals
Quotes are at least 15-min delayed:2024/09/28 14:44 EDT
Last
 58.78
+0.48 (+0.82%)
Day High 
59.08 
Prev. Close
58.3 
1-M High
64.21 
Volume 
184.64K 
Bid
24.69
Ask
58.88
Day Low
58 
Open
58.58 
1-M Low
52.53 
Market Cap 
1.23B 
Currency USD 
P/E 48.99 
%Yield -- 
10-SMA 59 
20-SMA 59.4 
50-SMA 60.67 
52-W High 70.81 
52-W Low 48.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.19/6.10
Enterprise Value
1.51B
Balance Sheet
Book Value Per Share
21.67
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
486.82M
Operating Revenue Per Share
10.14
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.74--0.000%-- 
VTRSViatris11.55-0.07-0.60%227.2PE
TEVATeva Pharmaceutical Industries Limited17.46-0.28-1.58%-- 
ELANElanco Animal Health14.32+0.59+4.30%-- 
HLNHaleon plc10.67+0.08+0.76%33.46PE
Quotes are at least 15-min delayed：2024/09/28 14:44 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.